检索结果 - Christopher Horvath

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.

    Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. 由 Christopher Horvath, Thomas J. Ferro, Gary Jesmok, Asrar B. Malik

    出版 1988
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases

    Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases 由 Masha Fridkis‐Hareli, Michael Storek, István Mazsaroff, Antonio M. Risitano, Ante S. Lundberg, Christopher Horvath, V. Michael Holers

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Non-thermal ablation of neural tissue with femtosecond laser pulses

    Non-thermal ablation of neural tissue with femtosecond laser pulses 由 Frieder H. Loesel, Joerg Fischer, Marcus Götz, Christopher Horvath, T. Juhász, F. Noack, Norbert Suhm, Josef F. Bille

    出版 1998
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells

    Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells 由 Kevin M. Friedman, Tracy E. Garrett, John Evans, Holly M. Horton, Howard J. Latimer, Stacie L. Seidel, Christopher Horvath, Richard A. Morgan

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers

    First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers 由 James C. Gilbert, Tia DeFeo-Fraulini, Renta Hutabarat, Christopher Horvath, Patricia G. Merlino, H. Nicholas Marsh, Judith M. Healy, Sleiman BouFakhreddine, Thomas V. Holohan, Robert G. Schaub

    出版 2007
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment opsonization

    The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment opsonization 由 Antonio M. Risitano, Rosario Notaro, Caterina Pascariello, Michela Sica, Luigi Del Vecchio, Christopher Horvath, Masha Fridkis‐Hareli, Carmine Selleri, Margaret A. Lindorfer, Ronald P. Taylor, Lucio Luzzatto, V. Michael Holers

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: